Nachrichten zur Swedish Orphan Biovitrum AB Aktie

Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus

Swedish Orphan Biovitrum AB (publ) (Sobi[®]) has established a medium term note programme with a framework amount of SEK 10…

Swedish Orphan Biovitrum AB (publ) 2024 Q1 - Results - Earnings Call Presentation

…

Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 •          Total revenue increased…

Orexo and Sobi agree to advance feasibility study with AmorphOX

· Orexo and Sobi advance collaboration after successful exploratory feasibility study with the company´s world-class drug delivery platform, AmorphOX® …

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2023 Earnings Call Transcript

…

Sobi’s Chairman of the Board resigns due to health reasons

Swedish Orphan Biovitrum AB’s (publ) (Sobi®) (STO: SOBI) (“Sobi”) Chairman of the Board Bo Jesper Hansen resigns, at his own…

Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (“Sobi”) has, as previously announced, carried out a share issue of series…

Sobi has completed the issuances of series C shares

The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (“Sobi”) has, as previously communicated, on 31…

Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically…

Sobi issues series C shares to fulfil its obligations under outstanding incentive programmes

The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (“Sobi”) has, based on the authorisation of…

Swedish Orphan Biovitrum AB (publ) (BIOVF) Q3 2023 Earnings Call Transcript

…

Swedish Orphan Biovitrum AB (publ) 2023 Q3 - Results - Earnings Call Presentation

…

Sobi appoints Lydia Abad-Franch as Head of R&D and Chief Medical Officer

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) today announced the appointment of Lydia Abad-Franch, MD, MBA as Senior Vice President,…

Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)

Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (“Sobi”) has, as previously announced, carried out a rights issue of common…

Sobi publishes prospectus regarding the rights issue

STOCKHOLM, Aug. 28, 2023 /PRNewswire/ -- The prospectus regarding the rights issue of ordinary shares in Swedish Orphan Biovitrum AB…

Sobi resolves on a rights issue of approximately SEK 6,024 million

STOCKHOLM, Aug. 22, 2023 /PRNewswire/ -- The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) ("Sobi"…

Sobi resolves on a rights issue of approximately SEK 6,024 million

The Board of Directors of Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO: SOBI) (“Sobi” or the “Company”) has, based on…

Swedish Orphan Biovitrum (BIOVF) Beats Q2 Earnings and Revenue Estimates

Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 27.27% and 16.48%, respectively, for the quarter ended June 2023.…

Sobi publishes Q2 2023 report: Growth and pipeline expansion

STOCKHOLM, July 18, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter…

Sobi publishes Q2 2023 report: Growth and pipeline expansion

Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the second quarter 2023 Second quarter 2023 · Total…

Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)

STOCKHOLM, July 18, 2023 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby…

Notice of Extraordinary General Meeting in Swedish Orphan Biovitrum AB (publ)

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Extraordinary General Meeting…

Swedish Orphan Biovitrum (BIOVF) Earnings Expected to Grow: Should You Buy?

Swedish Orphan Biovitrum (BIOVF) doesnt possess the right combination of the two key ingredients for a likely earnings beat in…

New number of shares and votes in Swedish Orphan Biovitrum AB (publ)

STOCKHOLM, June 30, 2023 /PRNewswire/ -- As per 30 June 2023, the total number of shares in Swedish Orphan Biovitrum…

New number of shares and votes in Swedish Orphan Biovitrum AB (publ)

As per 30 June 2023, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 311,336,796…

Sobi completes acquisition of CTI BioPharma Corp.

STOCKHOLM, June 26, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) and CTI BioPharma Corp. (NASDAQ:CTIC) (CTI) announced…

Are Medical Stocks Lagging Alcon (ALC) This Year?

Here is how Alcon (ALC) and Swedish Orphan Biovitrum (BIOVF) have performed compared to their sector so far this year....…

Apellis Pharmaceuticals, Swedish Orphan End ALS Efforts for Pegcetacoplan

Apellis Pharmaceuticals, Swedish Orphan End ALS Efforts for Pegcetacoplan...…

CTI BioPharma skyrockets on acquisition by Swedish Orphan ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Shares of CTI BioPharma Are Soaring Wednesday

A buyout offer from Swedish Orphan Biovitrum drove up the stocks price....…

Swedish Orphan Biovitrum: Ein Milliarden-Dollar-Deal bahnt sich an! Aktienanalyse

Kulmbach (www.aktiencheck.de) - Swedish Orphan Biovitrum-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

CTI BioPharma Shares Soar Premarket on Takeover by Swedish Orphan >CTIC

CTI BioPharma Shares Soar Premarket on Takeover by Swedish Orphan >CTIC...…

89 Prozent Aufschlag: Nächster Übernahme-Hammer im Biotech-Sektor

Die Übernahme-Aktivitäten im Biotech-Sektor verweilen auf einem hohen Niveau. Auch zur Mitte der Handelswoche bahnt sich ein weiterer Milliarden-Dollar-Deal an.…

Swedish Orphan Biovitrum Ab to acquire CTI BioPharma for $9.10 per share

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Swedish Orphan Biovitrum to acquire CTI BioPharma in a deal valued at $1.7 billion

Swedish Orphan Biovitrum AB SE:SOBI on Wednesday announced that it has entered into an agreement to acquire U.S.-based CTI BioPharma…

Swedish Orphan Biovitrum AB To Acquire CTI BioPharma

BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - CTI BioPharma (CTIC) has entered into a definitive agreement under which Swedish Orphan Biovitrum AB or Sobi…

Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.60, revenue of SEK5.24M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Swedish Orphan Biovitrum (BIOVF) Q1 Earnings and Revenues Beat Estimates

Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 54.55% and 5.57%, respectively, for the quarter ended March 2023.…

Sobi publishes Q1 2023 report: Continued solid progress

STOCKHOLM, April 27, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter…

Sanofi bekommt Astrazeneca-Anteil an RSV-Lizenz in USA

Von Cecilia Butini BARCELONA (Dow Jones)--Sanofi bekommt die volle kommerzielle Kontrolle über eine Antikörperbehandlung gegen das Respiratorische Synzytialvirus (RSV)…

Update to arrangements with Sobi and Sanofi

11 April 2023 07:00 BST Update to contractual arrangements between AstraZeneca, Swedish Orphan Biovitrum AB and Sanofi AstraZeneca, Swedish Orphan Biovitrum AB…

Sobi To Streamline Nirsevimab Agreement

LONDON (dpa-AFX) - Swedish Orphan Biovitrum AB or Sobi (SWTUY.PK) said that it has streamlined nirsevimab contractual arrangements. Nirsevimab economics…

Notice of Annual general meeting in Swedish Orphan Biovitrum AB (publ)

STOCKHOLM, March 30, 2023 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby…

Notice of Annual general meeting in Swedish Orphan Biovitrum AB (publ)

The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting…

FDA approves once-weekly efanesoctocog alfa, a new class of high-sustained factor VIII therapy for haemophilia A: Swedish Orphan Biovitrum AB

STOCKHOLM, Feb. 24, 2023 /PRNewswire/ -- Sobi® today announced that the US Food and Drug Administration (FDA) has approved efanesoctocog…

Sobi publishes Q4 and FY 2022 report: a good year and a solid future

STOCKHOLM, Feb. 8, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter…

Sobi publishes Q4 and FY 2022 report: a good year and a solid future

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi®) today announced its report for the fourth quarter and full year of 2022   Fourth quarter…

Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB (publ) ahead of the Annual General Meeting in 2023

STOCKHOLM, Nov. 18, 2022 /PRNewswire/ -- As previously communicated, Håkan Björklund, the current Chairman of the Board of Swedish Orphan…

Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB (publ) ahead of the Annual General Meeting in 2023

As previously communicated, Håkan Björklund, the current Chairman of the Board of Swedish Orphan Biovitrum AB (publ) (Sobi®), has announced…

Swedish Orphan Biovitrum (BIOVF) Beats Q3 Earnings Estimates

Swedish Orphan Biovitrum (BIOVF) delivered earnings and revenue surprises of 16.67% and 2.26%, respectively, for the quarter ended September 2022.…